Financial Union Society news on November 21st (Editor Zhou Ziyi) According to two informed sources on Wednesday (November 20), the elected President of the United States, Donald Trump, may choose John Hopkins University's surgeon and writer Martin Makary to lead the FDA.

Makary's major achievements in the medical field include being a co-developer of the 'Surgery Checklist,' a routine procedure for surgeons that has improved patient treatment outcomes and has been promoted globally by the World Health Organization (WHO).

His latest work, 'Blindspots,' was published in September. In promotional interviews for this book, he opposed what he called 'massive overtreatment' in the United States and referred to it as an 'epidemic of inappropriate care.'

Makary also advocates for a reevaluation of hormone replacement therapy in menopausal women, reducing excessive use of antibiotics, and reforming medical education.

However, a controversial point in Makary's career is that during the COVID-19 pandemic, he raised many concerns about public health issues, advocated for natural immunity, and opposed the requirement for COVID-19 vaccines.

Regarding the possible appointment reported by the media, Brian Hughes, a spokesperson for the Trump transition team, stated that he would not speculate or make any premature statements.

Another anti-vaccine advocate

As the most influential pharmaceutical regulatory agency globally, the FDA has a budget of over $7 billion. It is responsible for approving new treatment methods and ensuring they are safe and effective before entering the largest and most profitable markets. It has regulatory authority over human and veterinary drugs, biologics, medical devices, and vaccines.

Additionally, the agency is also responsible for maintaining safety standards for food supply, tobacco, cosmetics, and radiation products.

If Macari appoints an FDA commissioner and obtains Senate approval, he will succeed the current commissioner, Dr. Robert Califf, a cardiologist and researcher who previously served as an FDA commissioner in the Obama administration.

Furthermore, Macari will also report to the head of the U.S. Department of Health and Human Services after taking office. According to previous reports, Trump's nominee for U.S. Health Secretary is also a 'surprise choice'.

Last week, Trump nominated environmental activist Robert F. Kennedy Jr. as Secretary of Health and Human Services. Kennedy is also an anti-vaccine advocate with some controversial policy views. Since 2005, he has been promoting anti-vaccine information and publicly stating that there is opaque information within the U.S. government affecting public health.

Back in October during the election campaign, Trump had promised Kennedy, who supported his campaign, that if he returned to the White House, he would allow Kennedy to act 'crazily' on health issues.

Editor/Lambor